- Medical School - University of Toledo College of Medicine (2010-2014)
- Internship - Henry Ford Hospital (2014-2015), Transitional Year
- Residency - Fox Chase Cancer Center (2015-2019), Radiation Oncology
Vladimir Avkshtol, M.D.
- Radiation Oncology
- Skin Cancer
- Airway Cancer
Vladimir Avkshtol, M.D., is an Assistant Professor of Radiation Oncology at UT Southwestern Medical Center specializing in the treatment of head and neck cancers. It wasn’t until his third year of medical school working with cancer patients that he became interested in radiation oncology.
“Radiation oncology is such a unique field that utilizes a lot of the microscopic and anatomical knowledge that other medical and surgical specialties use, and combines them together,” says Dr. Avkshtol. “You then get to use this combined knowledge and apply it to cutting-edge technology. Along with the patients, this aspect really drew me to the field.”
Dr. Avkshtol earned his medical degree at the University of Toledo College of Medicine and Life Sciences. Following graduation, he completed his residency training in radiation oncology at Fox Chase Cancer Center in Philadelphia where he also served as Chief Resident.
Dr. Avkshtol is a member of the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the Radiological Society of North America (RSNA), and the American Brachytherapy Society (ABS).
Meet Dr. Avkshtol
As a head and neck specialist, Vladimir Avkshtol, M.D., is passionate about treating patients with all kinds of head and neck cancers, from more common diseases such as oropharynx cancer and larynx cancer, to unique cases such as cancers of the nasal sinuses.
“Radiation plays a large role in the treatment of head and neck cancer, and it’s a subspecialty that is particularly interesting because of the exciting research and improvements we see on the horizon,” he says. “UT Southwestern is committed to being on the forefront of medicine and along with our surgical and medical oncologist colleagues, we are excited to offer our head and neck cancer patients tomorrow’s treatments today.”
Dr. Avkshtol’s primary motivation as a radiation oncologist researcher revolves around reducing toxicity, reducing unnecessary treatment, and improving patients’ quality of life. Lowering the burden of treatment while giving patients the same or better chance of cure is his ultimate goal.
Dr. Avkshtol is proud to be part of a department that carries a great reputation for patient care, and wants patients to know that he'll treat them like one of his family members.
“Spending time with my patients and providing support and answering questions is ultimately the reason why I chose to go into radiation oncology; being my patients’ advocate is my one true constant role,” he says. “I want to make sure that my clinic is a place where no one would hesitate to refer their family member if one of them got sick.”
- American Brachytherapy Society (ABS)
- American Medical Association (AMA)
- American Radium Society (ARS)
- American Society of Clinical Oncology (ASCO)
- American Society for Radiation Oncology (ASTRO)
- Radiological Society of North America (RSNA)
- NCCN Fellows Recognition Program 2016
- Chief Resident, Department of Radiation Oncology, Fox Chase Cancer Center 2017-2018
- ASTRO’s Annual Meeting Travel Award 2018
- Best of ASTRO Abstract Selection 2018
- RSNA Roentgen Resident/Fellow Research Award 2018
- ASTRO’s Meet the Expert 2018
Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
Johnson MD, Avkshtol V, Baschnagel AM, Meyer K, Ye H, Grills IS, Chen PY, Maitz A, Olson RE, Pieper DR, Krauss DJ, International journal of radiation oncology, biology, physics 2016 Mar 94 3 537-43
What Are Medical Students in the United States Learning About Radiation Oncology? Results of a Multi-Institutional Survey.
Zaorsky NG, Shaikh T, Handorf E, Eastwick G, Hesney A, Scher ED, Jones RT, Showalter TN, Avkshtol V, Rice SR, Horwitz EM, Meyer JE, International journal of radiation oncology, biology, physics 2016 Feb 94 2 235-42
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.
Avkshtol V, Dong Y, Hayes SB, Hallman MA, Price RA, Sobczak ML, Horwitz EM, Zaorsky NG, Research and reports in urology 2016 8 145-58
- Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
- Treatment toxicity
- Radiation sensitivity
- Personalized medicine
- Skin Cancer
- Airway Cancer
- Ophthalmic Oncology
- Radiation Therapy for Head and Neck Cancer